$FRME

FIRST MERCHANTS CORP (FRME): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

FIRST MERCHANTS CORP (FRME) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. frme-20260701 0000712534 false 0000712534 2026-07-01 2026-07-01 0000712534 us-gaap:CommonStockMember 2026-07-01 2026-07-01 0000712534 frme:DepositarySharesMember 2026-07-01 2026-07-01 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PU

Original reporting
Published Jul 2, 2026, 8:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 2, 2026, 8:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$FRME
Neutral
medium confidence
Mentioned
$FRME
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$FRMENeutralLow
01

Why it matters

The company reports the resignation is effective immediately and not tied to disagreements; board size decreases from 13 to 12.

02

Market read

Traders may monitor for any follow-on 8-K naming a replacement director or committee changes, but the disclosed rationale suggests limited immediate impact.

03

What to watch

The 8-K excerpt does not specify whether Chiang chaired any key committees or whether a replacement director is planned; that could affect governance-sensitive investors.

Relevance 6/10Novelty 4/10Timing: filed after-hours on July 2, 2026 (event dated July 1)

Background

This is an SEC Form 8-K Item 5.02 governance disclosure covering director departure and related board size change.

Company-level read

Ticker impact

$FRMENeutralMedium confidence
Context

First Merchants disclosed Dr. Mung Chiang’s immediate board resignation and a reduction in board size from 13 to 12.

Expected impact

Low near-term impact; any reaction would likely be muted unless tied to committee/strategy changes not disclosed here.

Evidence & confidence

The filing states the resignation is due to relocation/professional responsibilities and not a disagreement; no financial targets, guidance, or operational changes are provided.

Market effects

Minimal; governance-only update without sector-wide regulatory or operational implications.

None indicated; company-specific board change.

None indicated.

Counterpoint

Even if the stated reason is relocation, the resignation could still signal internal governance/committee reshuffling that may matter for risk oversight.

Key entities

  • First Merchants Corporation

    US-listed bank holding company filing the 8-K about a director resignation and board size reduction.

  • Dr. Mung Chiang

    Director who resigned from the board effective immediately due to relocation/professional responsibilities.

Related articles

$FRMEMedAI 8/10

Why First Merchants (FRME) Shares Are Falling Today

First Merchants (FRME) shares fell about 5% after the company reported Q2 2026 results below Wall Street expectations. Adjusted EPS was $0.74 on revenue of $196.1 million versus estimates of $1.03 EPS and $202.7 million revenue. Net interest income was $158.9 million versus $164.3 million consensus.

$FRMEMed

First Merchants Q2 Earnings Call Highlights

First Merchants (NASDAQ:FRME) reported Q2 revenue growth, with net interest income up $7.6M quarter over quarter to $165.3M and non-interest income up $1.6M after normalizing. Deposit rate fell to 2.07%. Credit provision was $33M tied to two commercial credits. Tangible book value rose to $29.80; expense run-rate guidance $111M-$114M. Share repurchases totaled $38.3M YTD.

$FRMEMed

FIRST MERCHANTS CORP (FRME): Results of Operations and Financial Condition

FIRST MERCHANTS CORP (FRME) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a2q26earningsreleaseex991.htm EX-99.1 Document N / E / W / S R / E / L / E / A / S / E July 22, 2026 FOR IMMEDIATE RELEASE For more information, contact: Nicole M. Weaver, First Vice President and Director of Corporate Administration 765-521-7619 http://www.firstmerchan

$SKHYMed

SK Hynix’s $38 billion buildout has a name attached: Nvidia

SK Hynix (SKHY) approved about 54.3 trillion won (about $38.3B) for two memory plants through 2031, Reuters reported. About 35.2 trillion won funds a DRAM fab in Yongin (Y2) with construction starting July 2027 and first cleanroom June 2029. Remaining 19.1 trillion won supports a NAND plant in Cheongju. Reuters also said it is reviewing further shareholder returns.

$ITWMed

Illinois Tool Works Authorizes $6 Bln Buyback

Illinois Tool Works (ITW) said its board authorized a new share repurchase program of up to $6 billion. The board also approved a 7% increase in its regular annual cash dividend to $6.88 per share, effective with the Q4 dividend of $1.72 payable Oct. 9, 2026. ITW closed at $296.66 on Friday.

$JNJMed

Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson is offering $5.5 billion to settle most of more than 70,000 pending talc-related cancer lawsuits, according to the company. Claims allege ovarian cancer or mesothelioma linked to asbestos-contaminated talc. J&J denies wrongdoing and says cases lack merit. Prior orders include $966m (LA) and $1.5bn (Baltimore), with appeals planned.